T1 Mapping for the Study of Cardiac Hypertrophy

被引：1

作者：

Doltra A. ^{[1
]}

Nasser S.B. ^{[1
,2
]}

Messroghli D. ^{[1
,3
]}

Gebker R. ^{[1
,3
]}

Schnackenburg B. ^{[4
]}

Pieske B. ^{[1
,3
,5
]}

Kelle S. ^{[1
,3
]}

机构：

[1] Department of Internal Medicine/Cardiology, German Heart Institute Berlin, Augustenburger Platz 1, Berlin

[2] Department of Cardiology, Dar Al Fouad Hospital, Cairo

[3] DZHK (German Center for Cardiovascular Research), partner site Berlin, Berlin

[4] Philips Healthcare, Clinical Science, Hamburg

[5] Department of Internal Medicine and Cardiology, Charité Universitätsmedizin Berlin, Berlin

来源：

Current Cardiovascular Imaging Reports | 2015年 / 8卷 / 12期

关键词：

Cardiovascular magnetic resonance; ECV; Hypertrophic; Hypertrophy; T1; mapping;

D O I：

10.1007/s12410-015-9362-9

中图分类号：

学科分类号：

摘要：

Cardiovascular magnetic resonance has a fundamental role for diagnostic and prognostic assessment of cardiac hypertrophy. T1 mapping is a rapidly evolving field, and in the last years, many studies have applied this technique to study cardiac hypertrophy. In the current review, we discuss the results of the main studies on this topic, and we provide some insight on potential applications of this technique and unsolved questions that warrant further investigation. © 2015, Springer Science+Business Media New York.

引用

页数：7

共 50 条

[1]

Rockey D.C., Bell P.D., Hill J.A., Fibrosis—a common pathway to organ injury and failure, N Engl J Med, 373, (2015)

[2]

Hundley W.G., Bluemke D.A., Finn J.P., Et al., ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents, J Am Coll Cardiol, 55, pp. 2614-2662, (2010)

[3]

Kim R.J., Fieno D.S., Parrish T.B., Et al., Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function, Circulation, 100, pp. 1992-2002, (1999)

[4]

Messroghli D.R., Radjenovic A., Kozerke S., Higgins D.M., Sivananthan M.U., Ridgway J.P., Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart, Magn Reson Med, 52, pp. 141-146, (2004)

[5]

Wong T.C., Piehler K.M., Kang I.A., Et al., Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission, Eur Heart J, 35, pp. 657-664, (2014)

[6]

Klein C., Schmal T.R., Nekolla S.G., Schnackenburg B., Fleck E., Nagel E., Mechanism of late gadolinium enhancement in patients with acute myocardial infarction, J Cardiovasc Magn Reson, 9, pp. 653-658, (2007)

[7]

Amado L.C., Gerber B.L., Gupta S.N., Et al., Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model, J Am Coll Cardiol, 44, pp. 2383-2389, (2004)

[8]

Piechnik S.K., Ferreira V.M., Dall'Armellina E., Et al., Shortened modified look-locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold, J Cardiovasc Magn Reson, 12, (2010)

[9]

Chow K., Flewitt J.A., Green J.D., Pagano J.J., Friedrich M.G., Thompson R.B., Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping, Magn Reson Med, 71, pp. 2082-2095, (2014)

[10]

Flett A.S., Hayward M.P., Ashworth M.T., Et al., Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans, Circulation, 122, pp. 138-144, (2010)

← 1 2 3 4 5 →